DEXMETHYLPHENIDATE HYDROCHLORIDE

DEXMETHYLPHENIDATE HYDROCHLORIDE was reported 4282 times

DEXMETHYLPHENIDATE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAIR PLUCKING 2 0.1000
1 ADULTERATED PRODUCT 17 0.0850
2 NAIL PICKING 2 0.0444
3 DISRUPTIVE MOOD DYSREGULATION DISORDER 2 0.0270
4 SOMATIC SYMPTOM DISORDER 21 0.0194
5 CLAUSTROPHOBIA 20 0.0183
6 TOURETTE'S DISORDER 4 0.0176
7 OPPOSITIONAL DEFIANT DISORDER 6 0.0152
8 DEVELOPMENTAL REGRESSION 2 0.0147
9 CAPSULE PHYSICAL ISSUE 2 0.0138
10 EDUCATIONAL PROBLEM 20 0.0120
11 HAND-EYE COORDINATION IMPAIRED 2 0.0118
12 ONYCHOPHAGIA 3 0.0109
13 TIC 59 0.0108
14 BONE DEVELOPMENT ABNORMAL 3 0.0105
15 CHANGE IN SUSTAINED ATTENTION 3 0.0100
16 PREMENSTRUAL DYSPHORIC DISORDER 2 0.0099
17 DEFIANT BEHAVIOUR 3 0.0097
18 BULLOUS HAEMORRHAGIC DERMATOSIS 2 0.0095
19 PRODUCT TAMPERING 17 0.0095
20 HYPERMETABOLISM 5 0.0094
21 PRODUCT CONTAMINATION CHEMICAL 2 0.0092
22 PULSE ABNORMAL 22 0.0091
23 CROUP INFECTIOUS 7 0.0089
24 AMPHETAMINES POSITIVE 6 0.0080
25 AUTISM 8 0.0079
26 OVERGROWTH BACTERIAL 2 0.0074
27 DUODENOGASTRIC REFLUX 2 0.0072
28 BELLIGERENCE 3 0.0070
29 DISTRACTIBILITY 8 0.0069
30 GROWTH RETARDATION 20 0.0068
31 DERMATILLOMANIA 4 0.0067
32 RAYNAUD'S PHENOMENON 6 0.0064
33 BODY HEIGHT INCREASED 3 0.0061
34 SOCIAL ANXIETY DISORDER 4 0.0061
35 BOREDOM 2 0.0059
36 HYPERREFLEXIA 20 0.0057
37 DISTURBANCE IN SOCIAL BEHAVIOUR 13 0.0055
38 NEGATIVISM 4 0.0053
39 ADHESIVE TAPE USE 2 0.0052
40 POLYCYSTIC OVARIAN SYNDROME 2 0.0052
41 ANTISOCIAL BEHAVIOUR 5 0.0050
42 CATAPLEXY 7 0.0049
43 CLUBBING 2 0.0049
44 DRUG WITHDRAWAL HEADACHE 2 0.0048
45 IMPULSIVE BEHAVIOUR 18 0.0048
46 ATTENTION DEFICIT HYPERACTIVITY DISORDER 18 0.0043
47 ABNORMAL BEHAVIOUR 168 0.0042
48 OCULAR NEOPLASM 2 0.0042
49 OPIATES POSITIVE 2 0.0042
50 BLUNTED AFFECT 3 0.0041
51 EXCESSIVE EYE BLINKING 6 0.0041
52 NEUROLOGICAL SYMPTOM 22 0.0038
53 GRIMACING 3 0.0038
54 PSYCHOMOTOR HYPERACTIVITY 62 0.0037
55 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
56 DYSPRAXIA 2 0.0035
57 HEAD BANGING 2 0.0035
58 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 2 0.0034
59 CATHETER SITE PRURITUS 3 0.0034
60 IMPULSE-CONTROL DISORDER 7 0.0034
61 DARK CIRCLES UNDER EYES 5 0.0034
62 PRE-EXISTING CONDITION IMPROVED 19 0.0030
63 ENURESIS 12 0.0030
64 PSYCHOTIC BEHAVIOUR 3 0.0030
65 DISTURBANCE IN ATTENTION 158 0.0029
66 PAINFUL ERECTION 2 0.0029
67 ANGER 98 0.0029
68 AGGRESSION 144 0.0029
69 DRUG SCREEN NEGATIVE 5 0.0028
70 EYE ROLLING 2 0.0028
71 BEHAVIOUR DISORDER 15 0.0028
72 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
73 PARANOIA 47 0.0027
74 AUTISM SPECTRUM DISORDER 15 0.0027
75 TINEA INFECTION 3 0.0027
76 DRUG EFFECT VARIABLE 3 0.0026
77 SELF INJURIOUS BEHAVIOUR 8 0.0026
78 DYSLEXIA 3 0.0026
79 PERFORMANCE STATUS DECREASED 12 0.0026
80 UNDERWEIGHT 5 0.0025
81 SCREAMING 16 0.0025
82 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
83 PSEUDOMONAS TEST POSITIVE 2 0.0024
84 HAND-FOOT-AND-MOUTH DISEASE 2 0.0024
85 HOSTILITY 6 0.0024
86 ATONIC SEIZURES 2 0.0023
87 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
88 TERMINAL INSOMNIA 4 0.0023
89 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
90 CARBON DIOXIDE INCREASED 3 0.0022
91 CLUSTER HEADACHE 3 0.0022
92 PRODUCT APPEARANCE CONFUSION 2 0.0022
93 SUDDEN ONSET OF SLEEP 3 0.0022
94 HALLUCINATIONS, MIXED 9 0.0021
95 SLEEP TERROR 9 0.0021
96 NARCOLEPSY 4 0.0021
97 CEREBRAL PALSY 2 0.0021
98 MOOD SWINGS 67 0.0021
99 BRAIN INJURY 21 0.0021
100 SOCIAL AVOIDANT BEHAVIOUR 12 0.0021
101 STARING 5 0.0021
102 CONVERSION DISORDER 4 0.0021
103 GENERALISED ANXIETY DISORDER 3 0.0020
104 INTERCEPTED DRUG DISPENSING ERROR 3 0.0020
105 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
106 PRODUCT MEASURED POTENCY ISSUE 2 0.0020
107 LOGORRHOEA 7 0.0020
108 PRODUCT PHYSICAL ISSUE 40 0.0020
109 FOAMING AT MOUTH 4 0.0020
110 CRYING 72 0.0020
111 EMOTIONAL DISORDER 61 0.0020
112 IRRITABILITY 118 0.0020
113 BRUGADA SYNDROME 2 0.0019
114 SUICIDAL BEHAVIOUR 8 0.0019
115 SLEEP DEFICIT 4 0.0019
116 PRODUCT SUBSTITUTION ISSUE 108 0.0019
117 OBSESSIVE-COMPULSIVE DISORDER 15 0.0019
118 DISINHIBITION 3 0.0019
119 INFUSION SITE MASS 2 0.0018
120 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 10 0.0018
121 HENOCH-SCHONLEIN PURPURA 4 0.0018
122 ILLUSION 3 0.0018
123 EXPIRED DEVICE USED 6 0.0018
124 HYPERTENSIVE CRISIS 20 0.0018
125 ANXIETY DISORDER 6 0.0018
126 AFFECTIVE DISORDER 14 0.0018
127 DRUG TOLERANCE 9 0.0018
128 MOANING 2 0.0018
129 GYNAECOMASTIA 54 0.0017
130 HOMICIDAL IDEATION 7 0.0017
131 PRODUCT AVAILABILITY ISSUE 39 0.0017
132 NEGATIVE THOUGHTS 5 0.0017
133 ENERGY INCREASED 10 0.0017
134 ERECTION INCREASED 7 0.0017
135 LEARNING DISORDER 4 0.0017
136 BIPOLAR DISORDER 18 0.0017
137 FEBRILE CONVULSION 2 0.0016
138 DENTAL CARE 3 0.0016
139 BLADDER DISCOMFORT 2 0.0016
140 DYSPHEMIA 7 0.0016
141 BENIGN INTRACRANIAL HYPERTENSION 2 0.0016
142 SNORING 6 0.0016
143 THERAPEUTIC RESPONSE CHANGED 10 0.0016
144 GLUCOSE URINE PRESENT 2 0.0016
145 PHARYNGITIS STREPTOCOCCAL 17 0.0016
146 ENCEPHALITIS AUTOIMMUNE 2 0.0015
147 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
148 FEELING GUILTY 2 0.0015
149 HYPERPHAGIA 6 0.0015
150 BRUXISM 8 0.0015
151 PRIAPISM 5 0.0014
152 APPLICATION SITE INFLAMMATION 2 0.0014
153 CYSTIC FIBROSIS 8 0.0014
154 INSULIN RESISTANCE 3 0.0014
155 MYDRIASIS 18 0.0014
156 CATHETER SITE ERYTHEMA 3 0.0014
157 OCULOGYRIC CRISIS 3 0.0014
158 EXOPHTHALMOS 3 0.0014
159 SOMNAMBULISM 9 0.0014
160 INITIAL INSOMNIA 14 0.0014
161 APPETITE DISORDER 9 0.0014
162 PRODUCT LOT NUMBER ISSUE 3 0.0014
163 KNEE DEFORMITY 2 0.0013
164 CENTRAL VENOUS CATHETERISATION 4 0.0013
165 CRANIOCEREBRAL INJURY 4 0.0013
166 FEELING JITTERY 25 0.0013
167 DAYDREAMING 2 0.0013
168 DRUG DIVERSION 8 0.0013
169 FORMICATION 9 0.0013
170 MOOD ALTERED 35 0.0013
171 BACTERIAL VAGINOSIS 2 0.0013
172 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
173 NON-CARDIAC CHEST PAIN 4 0.0013
174 INAPPROPRIATE AFFECT 2 0.0013
175 CYSTITIS INTERSTITIAL 2 0.0012
176 COSTOCHONDRITIS 2 0.0012
177 BREAST ENLARGEMENT 4 0.0012
178 METABOLIC DISORDER 7 0.0012
179 CATHETER SITE HAEMORRHAGE 3 0.0012
180 AMENORRHOEA 21 0.0012
181 DECREASED INTEREST 7 0.0012
182 PERSONALITY CHANGE 11 0.0012
183 EXCORIATION 3 0.0012
184 DRUG DISPENSING ERROR 18 0.0012
185 DEAFNESS BILATERAL 2 0.0012
186 PETIT MAL EPILEPSY 6 0.0012
187 MUSCLE TWITCHING 27 0.0012
188 PRODUCT COLOUR ISSUE 6 0.0012
189 INCORRECT STORAGE OF DRUG 2 0.0012
190 SUICIDAL IDEATION 106 0.0012
191 DEVICE INFORMATION OUTPUT ISSUE 9 0.0012
192 TACHYPHRENIA 4 0.0012
193 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
194 PERSONALITY DISORDER 3 0.0011
195 DRUG PRESCRIBING ERROR 22 0.0011
196 EMOTIONAL POVERTY 2 0.0011
197 DRUG ADMINISTERED AT INAPPROPRIATE SITE 12 0.0011
198 HANGOVER 4 0.0011
199 YAWNING 3 0.0011
200 WITHDRAWAL SYNDROME 47 0.0011
201 INSURANCE ISSUE 17 0.0011
202 OBSESSIVE THOUGHTS 2 0.0011
203 CLUMSINESS 3 0.0011
204 ESSENTIAL HYPERTENSION 2 0.0011
205 RED BLOOD CELL COUNT INCREASED 3 0.0011
206 PARADOXICAL DRUG REACTION 4 0.0011
207 WRONG TECHNIQUE IN DRUG USAGE PROCESS 39 0.0011
208 HALLUCINATION, AUDITORY 17 0.0011
209 BLADDER SPASM 2 0.0011
210 THROAT CLEARING 4 0.0011
211 BLOOD PROLACTIN INCREASED 5 0.0011
212 COMMUNICATION DISORDER 4 0.0010
213 LIP PAIN 3 0.0010
214 AFFECT LABILITY 10 0.0010
215 WRONG PRODUCT ADMINISTERED 7 0.0010
216 DEVICE POWER SOURCE ISSUE 3 0.0010
217 STRABISMUS 3 0.0010
218 PSYCHOTIC DISORDER 30 0.0010
219 HYPERAEMIA 2 0.0010
220 TARDIVE DYSKINESIA 28 0.0010
221 LIBIDO INCREASED 2 0.0010
222 TREATMENT FAILURE 81 0.0010
223 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0010
224 COMPULSIVE SHOPPING 2 0.0010
225 PSYCHOTIC SYMPTOM 2 0.0010
226 SOCIAL PROBLEM 4 0.0010
227 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 4 0.0010
228 MAJOR DEPRESSION 7 0.0010
229 BLOOD CREATININE DECREASED 3 0.0010
230 SELF-INJURIOUS IDEATION 4 0.0010
231 BLEPHAROSPASM 6 0.0010
232 EAR SWELLING 2 0.0009
233 AGITATION 69 0.0009
234 PRODUCT SIZE ISSUE 5 0.0009
235 PRESCRIBED OVERDOSE 18 0.0009
236 TEARFULNESS 4 0.0009
237 DEREALISATION 2 0.0009
238 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
239 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
240 OEDEMA MOUTH 3 0.0009
241 OTITIS MEDIA 3 0.0009
242 DEPRESSED MOOD 48 0.0009
243 ACCIDENT AT WORK 2 0.0009
244 HYPOPHAGIA 23 0.0009
245 INFECTIOUS MONONUCLEOSIS 2 0.0009
246 ABNORMAL WEIGHT GAIN 11 0.0009
247 APPLICATION SITE IRRITATION 11 0.0009
248 EYE MOVEMENT DISORDER 6 0.0009
249 DEPRESSION SUICIDAL 3 0.0009
250 FRUSTRATION TOLERANCE DECREASED 7 0.0009
251 MIDDLE INSOMNIA 16 0.0009
252 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
253 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
254 RETCHING 18 0.0008
255 SLEEP APNOEA SYNDROME 16 0.0008
256 APPARENT DEATH 3 0.0008
257 PANIC REACTION 6 0.0008
258 PRODUCT USE COMPLAINT 13 0.0008
259 TENSION 5 0.0008
260 BLOOD PHOSPHORUS DECREASED 3 0.0008
261 BREATH ODOUR 2 0.0008
262 FEAR 22 0.0008
263 OBESITY 13 0.0008
264 HYPOMANIA 3 0.0008
265 COELIAC DISEASE 8 0.0008
266 LIVER INJURY 20 0.0008
267 CEREBRAL DISORDER 6 0.0008
268 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
269 SCOLIOSIS 5 0.0008
270 HALLUCINATION, VISUAL 17 0.0008
271 CONVULSION 46 0.0008
272 INFUSION SITE EXTRAVASATION 5 0.0008
273 EATING DISORDER 17 0.0008
274 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
275 MICTURITION URGENCY 9 0.0008
276 PARKINSON'S DISEASE 2 0.0008
277 GALACTORRHOEA 5 0.0008
278 FOOD ALLERGY 6 0.0008
279 CONCUSSION 6 0.0008
280 PANIC DISORDER 3 0.0008
281 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
282 HYPERPROLACTINAEMIA 5 0.0008
283 CATHETER SITE PAIN 2 0.0008
284 GRAND MAL CONVULSION 7 0.0008
285 PRODUCT FORMULATION ISSUE 5 0.0008
286 PRODUCT QUALITY ISSUE 102 0.0008
287 OVERWEIGHT 4 0.0007
288 HALLUCINATION 56 0.0007
289 SPINAL FUSION SURGERY 3 0.0007
290 LIP BLISTER 2 0.0007
291 APPLICATION SITE HAEMORRHAGE 2 0.0007
292 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
293 MANIA 12 0.0007
294 APPLICATION SITE ERYTHEMA 19 0.0007
295 STREPTOCOCCAL INFECTION 4 0.0007
296 DIABETIC COMA 2 0.0007
297 EAR INFECTION 19 0.0007
298 DRUG TOLERANCE DECREASED 2 0.0007
299 APPLICATION SITE PRURITUS 16 0.0007
300 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
301 INABILITY TO AFFORD MEDICATION 7 0.0007
302 GENERALISED ERYTHEMA 4 0.0007
303 BRAIN FOG 11 0.0007
304 ANXIETY 199 0.0007
305 POOR QUALITY DEVICE USED 7 0.0007
306 THINKING ABNORMAL 13 0.0007
307 VISUAL DISTURBANCE 4 0.0007
308 FEELING ABNORMAL 167 0.0007
309 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
310 TONGUE DISORDER 5 0.0007
311 DECREASED APPETITE 160 0.0007
312 DRUG LEVEL DECREASED 7 0.0007
313 BILIARY COLIC 2 0.0007
314 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
315 EUPHORIC MOOD 7 0.0007
316 RESTLESSNESS 25 0.0007
317 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
318 CREPITATIONS 2 0.0007
319 DYSTONIA 13 0.0007
320 ATYPICAL PNEUMONIA 2 0.0007
321 GASTROENTERITIS VIRAL 12 0.0007
322 LOSS OF EMPLOYMENT 2 0.0007
323 DRUG EFFECT DELAYED 3 0.0007
324 LETHARGY 38 0.0007
325 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
326 PENILE PAIN 2 0.0007
327 PERIPHERAL COLDNESS 9 0.0007
328 DRUG EFFECT DECREASED 35 0.0006
329 SEDATION 17 0.0006
330 HUNGER 9 0.0006
331 CYANOSIS 10 0.0006
332 DRUG EFFECT INCREASED 2 0.0006
333 INTENTIONAL DOSE OMISSION 18 0.0006
334 INCREASED APPETITE 12 0.0006
335 COLD SWEAT 11 0.0006
336 DEPRESSION 141 0.0006
337 REBOUND EFFECT 7 0.0006
338 HORMONE LEVEL ABNORMAL 3 0.0006
339 THERAPY CHANGE 6 0.0006
340 NEAR DEATH EXPERIENCE 2 0.0006
341 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0006
342 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
343 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
344 CHOLECYSTITIS CHRONIC 4 0.0006
345 POTENTIATING DRUG INTERACTION 2 0.0006
346 HEART RATE INCREASED 59 0.0006
347 INTENTIONAL SELF-INJURY 12 0.0006
348 NERVOUSNESS 31 0.0006
349 DYSKINESIA 24 0.0006
350 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
351 DEVICE MECHANICAL ISSUE 8 0.0006
352 DRUG INEFFECTIVE 769 0.0006
353 PERIPHERAL VASCULAR DISORDER 3 0.0006
354 TRISMUS 3 0.0006
355 DROOLING 4 0.0006
356 POLYMENORRHOEA 2 0.0006
357 SOMNOLENCE 116 0.0006
358 PALPITATIONS 67 0.0006
359 EAR PAIN 11 0.0006
360 THIRST 10 0.0006
361 FRUSTRATION 2 0.0006
362 MEDICATION ERROR 31 0.0006
363 IMPAIRED QUALITY OF LIFE 8 0.0006
364 DRUG ADMINISTRATION ERROR 17 0.0006
365 INSOMNIA 147 0.0006
366 SKIN LACERATION 6 0.0006
367 NIGHTMARE 19 0.0005
368 PANIC ATTACK 20 0.0005
369 APATHY 8 0.0005
370 NONSPECIFIC REACTION 3 0.0005
371 AMYLASE INCREASED 2 0.0005
372 HYPERACUSIS 2 0.0005
373 ANGIOPATHY 3 0.0005
374 FACE INJURY 2 0.0005
375 PRODUCT TASTE ABNORMAL 7 0.0005
376 APNOEA 4 0.0005
377 THERAPEUTIC PRODUCT EFFECT DECREASED 23 0.0005
378 MULTIPLE ALLERGIES 4 0.0005
379 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
380 DRUG SCREEN POSITIVE 4 0.0005
381 HYPERHIDROSIS 65 0.0005
382 NECK PAIN 28 0.0005
383 FOREIGN BODY 2 0.0005
384 TYPE 1 DIABETES MELLITUS 3 0.0005
385 HEPATITIS B 3 0.0005
386 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
387 ILLNESS 51 0.0005
388 DEVICE BREAKAGE 20 0.0005
389 APPLICATION SITE DISCOLOURATION 2 0.0005
390 UNEVALUABLE EVENT 37 0.0005
391 POOR VENOUS ACCESS 5 0.0005
392 WEIGHT FLUCTUATION 5 0.0005
393 SWELLING FACE 31 0.0005
394 SKIN PLAQUE 4 0.0005
395 FEELING HOT 29 0.0005
396 INCONTINENCE 5 0.0005
397 URINARY INCONTINENCE 14 0.0005
398 SEROTONIN SYNDROME 9 0.0005
399 VITAMIN D DECREASED 4 0.0005
400 WEIGHT INCREASED 104 0.0005
401 TACHYCARDIA 41 0.0005
402 MENTAL DISORDER 20 0.0005
403 DYSGRAPHIA 3 0.0005
404 MENTAL IMPAIRMENT 11 0.0005
405 RESPIRATORY RATE INCREASED 4 0.0005
406 IMPLANT SITE PAIN 2 0.0004
407 BREAST MASS 3 0.0004
408 ADVERSE DRUG REACTION 40 0.0004
409 PRODUCT LABEL ISSUE 3 0.0004
410 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
411 AKATHISIA 6 0.0004
412 SLEEP DISORDER 31 0.0004
413 WHEEZING 26 0.0004
414 EAR DISORDER 2 0.0004
415 MOVEMENT DISORDER 14 0.0004
416 NERVE COMPRESSION 4 0.0004
417 COORDINATION ABNORMAL 6 0.0004
418 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 87 0.0004
419 FEAR OF INJECTION 3 0.0004
420 PRODUCT PRESCRIBING ERROR 10 0.0004
421 RECALLED PRODUCT ADMINISTERED 4 0.0004
422 DRY MOUTH 34 0.0004
423 MUSCLE RIGIDITY 5 0.0004
424 LIMB OPERATION 2 0.0004
425 HYPERCHOLESTEROLAEMIA 4 0.0004
426 LOSS OF CONSCIOUSNESS 53 0.0004
427 PRODUCT DISPENSING ERROR 9 0.0004
428 INTENTIONAL PRODUCT MISUSE 36 0.0004
429 DYSPHAGIA 39 0.0004
430 AUTOIMMUNE DISORDER 4 0.0004
431 NO THERAPEUTIC RESPONSE 5 0.0004
432 PSYCHIATRIC SYMPTOM 3 0.0004
433 BODY TEMPERATURE DECREASED 4 0.0004
434 FOOT OPERATION 2 0.0004
435 DIABETIC NEUROPATHY 2 0.0004
436 FEELING DRUNK 3 0.0004
437 THERAPY NON-RESPONDER 18 0.0004
438 BLOOD PRESSURE INCREASED 61 0.0004
439 ABDOMINAL PAIN UPPER 82 0.0004
440 MIGRAINE 38 0.0004
441 OSTEOPENIA 6 0.0004
442 DRY THROAT 4 0.0004
443 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
444 LIPASE INCREASED 3 0.0004
445 DISSOCIATION 3 0.0004
446 SEIZURE 45 0.0004
447 ANOREXIA 5 0.0004
448 NO ADVERSE EVENT 70 0.0004
449 DELUSION 6 0.0004
450 HYPERSOMNIA 11 0.0004
451 DRUG DOSE OMISSION BY DEVICE 30 0.0004
452 APLASTIC ANAEMIA 2 0.0004
453 HEAD INJURY 12 0.0004
454 DYSMENORRHOEA 5 0.0004
455 JOINT INJURY 8 0.0004
456 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
457 TREMOR 62 0.0004
458 PRODUCT RESIDUE PRESENT 2 0.0004
459 PRESYNCOPE 9 0.0004
460 PALLOR 10 0.0004
461 CHEST PAIN 68 0.0004
462 POLYURIA 3 0.0004
463 JAW DISORDER 2 0.0004
464 SPEECH DISORDER 19 0.0004
465 SINUSITIS 37 0.0004
466 POLLAKIURIA 15 0.0004
467 CONFUSIONAL STATE 58 0.0004
468 HEART RATE ABNORMAL 2 0.0004
469 MEMORY IMPAIRMENT 49 0.0004
470 EMOTIONAL DISTRESS 43 0.0004
471 PRODUCT DOSE OMISSION 23 0.0004
472 BLOOD PRESSURE ABNORMAL 7 0.0004
473 GRANULOCYTOPENIA 2 0.0004
474 DERMATITIS CONTACT 4 0.0004
475 CHOLECYSTECTOMY 4 0.0003
476 VISION BLURRED 48 0.0003
477 SKIN HYPERPIGMENTATION 3 0.0003
478 EXERCISE TOLERANCE DECREASED 2 0.0003
479 PRODUCT DOSE OMISSION ISSUE 102 0.0003
480 HYSTERECTOMY 3 0.0003
481 FEEDING DISORDER 7 0.0003
482 HYPERVENTILATION 2 0.0003
483 RASH MACULAR 12 0.0003
484 BODY TEMPERATURE INCREASED 7 0.0003
485 BLOOD CALCIUM INCREASED 3 0.0003
486 SPINAL OSTEOARTHRITIS 3 0.0003
487 SEXUAL DYSFUNCTION 4 0.0003
488 HEAD DISCOMFORT 6 0.0003
489 PLEURISY 2 0.0003
490 WRONG DRUG ADMINISTERED 3 0.0003
491 WEIGHT DECREASED 93 0.0003
492 THERAPY CESSATION 17 0.0003
493 VIRAL INFECTION 11 0.0003
494 ECONOMIC PROBLEM 5 0.0003
495 SCHIZOPHRENIA 4 0.0003
496 FIBROMYALGIA 8 0.0003
497 DISORIENTATION 13 0.0003
498 ABDOMINAL DISCOMFORT 55 0.0003
499 SKIN DISCOLOURATION 15 0.0003
500 ANKLE FRACTURE 5 0.0003
501 PHARYNGITIS 4 0.0003
502 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
503 NASAL DRYNESS 2 0.0003
504 MUSCULAR WEAKNESS 36 0.0003
505 ABDOMINAL DISTENSION 33 0.0003
506 PRODUCT COMPLAINT 8 0.0003
507 STEVENS-JOHNSON SYNDROME 7 0.0003
508 ULCER 5 0.0003
509 SUICIDE ATTEMPT 19 0.0003
510 ROAD TRAFFIC ACCIDENT 13 0.0003
511 INFUSION SITE PAIN 4 0.0003
512 UNRESPONSIVE TO STIMULI 8 0.0003
513 POOR QUALITY DRUG ADMINISTERED 2 0.0003
514 MUSCLE TIGHTNESS 5 0.0003
515 PRODUCT ADHESION ISSUE 11 0.0003
516 VITAMIN D DEFICIENCY 3 0.0003
517 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
518 AMNESIA 20 0.0003
519 PARAESTHESIA 48 0.0003
520 KNEE OPERATION 3 0.0003
521 PRODUCT PREPARATION ISSUE 2 0.0003
522 VOMITING 141 0.0003
523 HEADACHE 188 0.0003
524 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
525 BRONCHIECTASIS 2 0.0003
526 SINUS CONGESTION 4 0.0003
527 CONDITION AGGRAVATED 90 0.0003
528 SLUGGISHNESS 3 0.0003
529 HYPOAESTHESIA 44 0.0003
530 IMPAIRED GASTRIC EMPTYING 4 0.0003
531 BLOOD TESTOSTERONE DECREASED 2 0.0003
532 EAR DISCOMFORT 3 0.0003
533 DYSARTHRIA 11 0.0003
534 CROHN'S DISEASE 2 0.0003
535 EXTRASYSTOLES 2 0.0003
536 PRODUCT ODOUR ABNORMAL 3 0.0003
537 SYRINGE ISSUE 5 0.0003
538 HYPERSENSITIVITY 53 0.0003
539 SCRATCH 3 0.0003
540 JOINT DISLOCATION 3 0.0003
541 FULL BLOOD COUNT ABNORMAL 3 0.0003
542 SEASONAL ALLERGY 4 0.0003
543 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
544 HAND FRACTURE 2 0.0003
545 EXTRAPYRAMIDAL DISORDER 7 0.0003
546 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
547 PRODUCT SUPPLY ISSUE 2 0.0003
548 HEREDITARY ANGIOEDEMA 3 0.0003
549 DRUG INTOLERANCE 27 0.0003
550 POOR QUALITY SLEEP 6 0.0003
551 INFLUENZA 31 0.0003
552 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
553 FAECES SOFT 2 0.0003
554 INTENTIONAL UNDERDOSE 2 0.0003
555 APPLICATION SITE PAIN 6 0.0003
556 EXTRA DOSE ADMINISTERED 11 0.0003
557 BLINDNESS TRANSIENT 2 0.0003
558 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
559 VENTRICULAR FIBRILLATION 3 0.0003
560 SKIN HAEMORRHAGE 4 0.0003
561 ORAL PAIN 6 0.0003
562 ECZEMA 14 0.0003
563 IMPAIRED DRIVING ABILITY 3 0.0003
564 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
565 HYPERTHERMIA 2 0.0003
566 NEPHROLITHIASIS 12 0.0003
567 DIZZINESS 130 0.0003
568 NASOPHARYNGITIS 48 0.0003
569 NAUSEA 206 0.0003
570 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
571 THROAT TIGHTNESS 7 0.0003
572 EYELID OEDEMA 3 0.0003
573 LUNG INFECTION 4 0.0003
574 SKIN FISSURES 5 0.0003
575 MENORRHAGIA 5 0.0003
576 ABNORMAL DREAMS 7 0.0003
577 SINUS DISORDER 5 0.0003
578 FURUNCLE 2 0.0003
579 NASAL DISCOMFORT 2 0.0003
580 FEELING COLD 7 0.0003
581 MACULAR DEGENERATION 3 0.0003
582 UPPER LIMB FRACTURE 5 0.0003
583 HYPOTHYROIDISM 8 0.0003
584 WRIST FRACTURE 3 0.0003
585 HYPERTENSION 53 0.0002
586 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
587 COUGH 70 0.0002
588 DRUG DOSE OMISSION 41 0.0002
589 MYASTHENIA GRAVIS 2 0.0002
590 RHINORRHOEA 16 0.0002
591 PRODUCT ADMINISTRATION ERROR 5 0.0002
592 DERMATITIS ATOPIC 13 0.0002
593 MUSCLE SPASMS 45 0.0002
594 URTICARIA 41 0.0002
595 MUSCLE SPASTICITY 3 0.0002
596 ABNORMAL FAECES 2 0.0002
597 BRONCHITIS 18 0.0002
598 CYST 3 0.0002
599 MENSTRUAL DISORDER 2 0.0002
600 HEMIPLEGIA 2 0.0002
601 INTENTIONAL DRUG MISUSE 5 0.0002
602 ASTHMA 27 0.0002
603 SURGERY 14 0.0002
604 COGNITIVE DISORDER 11 0.0002
605 CHEST DISCOMFORT 24 0.0002
606 IMPAIRED WORK ABILITY 5 0.0002
607 SCAR 4 0.0002
608 ROTATOR CUFF SYNDROME 3 0.0002
609 PSEUDOMONAS INFECTION 2 0.0002
610 MALAISE 102 0.0002
611 DRY SKIN 31 0.0002
612 RASH GENERALISED 6 0.0002
613 HIATUS HERNIA 3 0.0002
614 PRURITUS GENERALISED 5 0.0002
615 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
616 CARDIAC MURMUR 2 0.0002
617 DIPLOPIA 6 0.0002
618 NODULE 3 0.0002
619 NAIL DISORDER 2 0.0002
620 BEDRIDDEN 3 0.0002
621 IMMUNOSUPPRESSION 2 0.0002
622 LIMB DISCOMFORT 7 0.0002
623 FATIGUE 176 0.0002
624 PURPURA 2 0.0002
625 SWOLLEN TONGUE 7 0.0002
626 GALLBLADDER DISORDER 4 0.0002
627 FACIAL PAIN 2 0.0002
628 MENSTRUATION IRREGULAR 6 0.0002
629 QUALITY OF LIFE DECREASED 3 0.0002
630 PRODUCT USE ISSUE 42 0.0002
631 GLOSSODYNIA 5 0.0002
632 GASTROINTESTINAL DISORDER 20 0.0002
633 GASTROINTESTINAL INFECTION 2 0.0002
634 DEVELOPMENTAL DELAY 2 0.0002
635 CHROMATURIA 5 0.0002
636 COMPLICATION OF DEVICE REMOVAL 4 0.0002
637 DRY EYE 11 0.0002
638 RESTLESS LEGS SYNDROME 4 0.0002
639 OSTEOPOROSIS 9 0.0002
640 ACCIDENTAL OVERDOSE 8 0.0002
641 INCREASED TENDENCY TO BRUISE 2 0.0002
642 DYSURIA 8 0.0002
643 OROPHARYNGEAL PAIN 20 0.0002
644 APPENDICITIS 2 0.0002
645 DEFORMITY 2 0.0002
646 EPISTAXIS 16 0.0002
647 FLANK PAIN 2 0.0002
648 PHOTOPHOBIA 4 0.0002
649 LACERATION 2 0.0002
650 STAPHYLOCOCCAL INFECTION 7 0.0002
651 VISUAL ACUITY REDUCED 7 0.0002
652 PRODUCT PACKAGING ISSUE 2 0.0002
653 VISUAL IMPAIRMENT 26 0.0002
654 CONTUSION 20 0.0002
655 HYPOKINESIA 3 0.0002
656 NEURALGIA 5 0.0002
657 UNDERDOSE 15 0.0002
658 CHOKING 4 0.0002
659 ERYTHEMA 42 0.0002
660 INJECTION SITE URTICARIA 5 0.0002
661 HEPATOMEGALY 2 0.0002
662 SKIN EXFOLIATION 17 0.0002
663 TREATMENT NONCOMPLIANCE 11 0.0002
664 HYPOTONIA 2 0.0002
665 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
666 RASH 87 0.0002
667 HEART RATE DECREASED 7 0.0002
668 ANAPHYLACTIC REACTION 11 0.0002
669 THERAPEUTIC RESPONSE DECREASED 12 0.0002
670 HYPOTHERMIA 2 0.0002
671 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
672 PYREXIA 68 0.0002
673 EPILEPSY 6 0.0002
674 MOTOR DYSFUNCTION 2 0.0002
675 THERAPY INTERRUPTED 14 0.0002
676 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
677 NEUTROPHIL COUNT INCREASED 2 0.0002
678 PHARYNGEAL OEDEMA 3 0.0002
679 DRUG EFFECT INCOMPLETE 7 0.0002
680 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
681 NERVOUS SYSTEM DISORDER 6 0.0002
682 RESPIRATORY TRACT INFECTION 5 0.0002
683 PETECHIAE 2 0.0002
684 ANHEDONIA 5 0.0002
685 OCULAR HYPERAEMIA 9 0.0002
686 DEVICE ISSUE 17 0.0002
687 INCORRECT DOSE ADMINISTERED 43 0.0002
688 EYE SWELLING 7 0.0002
689 BREAST PAIN 2 0.0002
690 IRRITABLE BOWEL SYNDROME 4 0.0002
691 PAIN OF SKIN 5 0.0002
692 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
693 INJURY 13 0.0002
694 ACNE 14 0.0002
695 DEVICE LEAKAGE 8 0.0002
696 BACK INJURY 2 0.0002
697 CONSTIPATION 40 0.0002
698 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
699 ASPIRATION 2 0.0002
700 DRUG WITHDRAWAL SYNDROME 16 0.0002
701 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
702 DRUG LEVEL INCREASED 3 0.0002
703 RESPIRATORY DISTRESS 5 0.0002
704 BLOOD PRESSURE DECREASED 12 0.0002
705 EXPIRED PRODUCT ADMINISTERED 6 0.0002
706 FOOT DEFORMITY 2 0.0002
707 DISCOMFORT 11 0.0002
708 LIP SWELLING 6 0.0002
709 GAIT INABILITY 6 0.0002
710 HAEMOPTYSIS 5 0.0002
711 BLOOD UREA INCREASED 3 0.0002
712 OCULAR DISCOMFORT 2 0.0002
713 FISTULA 2 0.0002
714 EYE INFECTION 2 0.0002
715 HEART RATE IRREGULAR 4 0.0002
716 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
717 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
718 NEOPLASM 2 0.0002
719 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
720 ASTHENIA 65 0.0002
721 BLINDNESS 7 0.0002
722 NEEDLE ISSUE 5 0.0002
723 BLOOD CHOLESTEROL INCREASED 8 0.0002
724 OFF LABEL USE 150 0.0002
725 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
726 SYNCOPE 17 0.0002
727 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
728 LYMPHOCYTE COUNT DECREASED 3 0.0002
729 DYSPNOEA 96 0.0002
730 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
731 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
732 BACTERAEMIA 2 0.0002
733 DISEASE RECURRENCE 8 0.0002
734 CHOLECYSTITIS 2 0.0002
735 PRODUCTIVE COUGH 8 0.0002
736 ACCIDENT 2 0.0002
737 RESPIRATORY DISORDER 5 0.0002
738 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
739 BLOOD PRESSURE FLUCTUATION 4 0.0002
740 DIABETIC KETOACIDOSIS 4 0.0002
741 TOOTHACHE 3 0.0002
742 APHASIA 5 0.0002
743 NOCTURIA 2 0.0002
744 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
745 INJECTION SITE BRUISING 13 0.0002
746 INJECTION SITE EXTRAVASATION 2 0.0002
747 HEPATIC ENZYME INCREASED 11 0.0002
748 TOXICITY TO VARIOUS AGENTS 27 0.0002
749 BLOOD SODIUM DECREASED 3 0.0002
750 FOOT FRACTURE 3 0.0002
751 MUSCULOSKELETAL DISORDER 3 0.0002
752 DRUG INTERACTION 25 0.0002
753 DEHYDRATION 21 0.0002
754 DEVICE DEPLOYMENT ISSUE 2 0.0002
755 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
756 THROAT IRRITATION 7 0.0002
757 HERNIA 3 0.0002
758 ERUCTATION 3 0.0002
759 EXPOSURE VIA SKIN CONTACT 4 0.0002
760 PRURITUS 59 0.0002
761 SKIN IRRITATION 7 0.0002
762 INCORRECT PRODUCT STORAGE 2 0.0002
763 INFECTION 22 0.0002
764 IMMUNE SYSTEM DISORDER 2 0.0002
765 DISABILITY 3 0.0002
766 PAIN 93 0.0002
767 HAEMATOCRIT DECREASED 3 0.0002
768 ADVERSE REACTION 2 0.0002
769 FUNGAL INFECTION 5 0.0001
770 PREGNANCY 3 0.0001
771 ILL-DEFINED DISORDER 9 0.0001
772 VERTIGO 9 0.0001
773 RASH PRURITIC 8 0.0001
774 FALL 49 0.0001
775 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
776 DRUG TOXICITY 2 0.0001
777 PRODUCT PREPARATION ERROR 3 0.0001
778 SKIN LESION 4 0.0001
779 GASTRIC DISORDER 5 0.0001
780 APPLICATION SITE RASH 2 0.0001
781 EXPOSURE DURING PREGNANCY 9 0.0001
782 PROCEDURAL PAIN 4 0.0001
783 MENTAL STATUS CHANGES 4 0.0001
784 DEVICE USE ERROR 5 0.0001
785 MASS 2 0.0001
786 COVID-19 25 0.0001
787 BLOOD TEST ABNORMAL 2 0.0001
788 DEVICE OCCLUSION 2 0.0001
789 LYMPHOPENIA 2 0.0001
790 PAIN IN JAW 4 0.0001
791 INTENTIONAL OVERDOSE 9 0.0001
792 PARALYSIS 2 0.0001
793 SKIN BURNING SENSATION 10 0.0001
794 ACCIDENTAL UNDERDOSE 2 0.0001
795 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
796 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
797 GASTROENTERITIS 2 0.0001
798 DYSPHONIA 8 0.0001
799 NASAL CONGESTION 8 0.0001
800 CARDIOMYOPATHY 2 0.0001
801 TOOTH DISORDER 3 0.0001
802 INJECTION SITE PAIN 41 0.0001
803 BACK PAIN 31 0.0001
804 BONE LOSS 2 0.0001
805 HYPOAESTHESIA ORAL 2 0.0001
806 INTESTINAL OBSTRUCTION 5 0.0001
807 DYSPEPSIA 13 0.0001
808 BRADYCARDIA 7 0.0001
809 DEVICE FAILURE 2 0.0001
810 GAIT DISTURBANCE 25 0.0001
811 DEVICE ADHESION ISSUE 2 0.0001
812 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
813 DEVICE RELATED INFECTION 2 0.0001
814 ABDOMINAL PAIN 30 0.0001
815 BASAL CELL CARCINOMA 2 0.0001
816 DEVICE MALFUNCTION 9 0.0001
817 CHILLS 15 0.0001
818 FLUSHING 13 0.0001
819 CYSTITIS 4 0.0001
820 RASH ERYTHEMATOUS 6 0.0001
821 INJECTION SITE HAEMORRHAGE 10 0.0001
822 OVERDOSE 27 0.0001
823 ABORTION SPONTANEOUS 5 0.0001
824 BLISTER 7 0.0001
825 OXYGEN SATURATION DECREASED 7 0.0001
826 NIGHT SWEATS 4 0.0001
827 EYE PAIN 7 0.0001
828 BACK DISORDER 2 0.0001
829 NEUTROPHIL COUNT DECREASED 5 0.0001
830 CHOLELITHIASIS 4 0.0001
831 ABASIA 3 0.0001
832 RHABDOMYOLYSIS 5 0.0001
833 ADVERSE EVENT 11 0.0001
834 TYPE 2 DIABETES MELLITUS 4 0.0001
835 HEMIPARESIS 2 0.0001
836 CIRCULATORY COLLAPSE 2 0.0001
837 METRORRHAGIA 2 0.0001
838 ERECTILE DYSFUNCTION 3 0.0001
839 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
840 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
841 SKIN ULCER 3 0.0001
842 BALANCE DISORDER 10 0.0001
843 STOMATITIS 7 0.0001
844 DEVICE DEFECTIVE 2 0.0001
845 NEOPLASM PROGRESSION 4 0.0001
846 DEVICE DISLOCATION 5 0.0001
847 ORTHOSTATIC HYPOTENSION 2 0.0001
848 DEAFNESS 3 0.0001
849 GASTRITIS 3 0.0001
850 URINARY TRACT INFECTION 19 0.0001
851 MOBILITY DECREASED 8 0.0001
852 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
853 LIMB INJURY 3 0.0001
854 BONE DISORDER 2 0.0001
855 INFLUENZA LIKE ILLNESS 9 0.0001
856 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
857 RESPIRATORY ARREST 3 0.0001
858 HYPOKALAEMIA 5 0.0001
859 INJECTION SITE MASS 4 0.0001
860 CONJUNCTIVITIS 2 0.0001
861 DEEP VEIN THROMBOSIS 7 0.0001
862 DYSGEUSIA 8 0.0001
863 BACTERIAL INFECTION 2 0.0001
864 COLITIS 4 0.0001
865 GASTRIC ULCER 2 0.0001
866 DIABETES MELLITUS 8 0.0001
867 MULTIPLE SCLEROSIS 5 0.0001
868 HERPES ZOSTER 6 0.0001
869 POST PROCEDURAL COMPLICATION 2 0.0001
870 LOWER LIMB FRACTURE 2 0.0001
871 ACUTE RESPIRATORY FAILURE 2 0.0001
872 GLAUCOMA 2 0.0001
873 ARTHRALGIA 43 0.0001
874 LIVER FUNCTION TEST ABNORMAL 3 0.0001
875 DYSSTASIA 3 0.0001
876 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
877 ORAL HERPES 2 0.0001
878 LUNG DISORDER 5 0.0001
879 PNEUMONIA 33 0.0001
880 INJECTION SITE REACTION 7 0.0001
881 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
882 PRESCRIBED UNDERDOSE 2 0.0001
883 CELLULITIS 5 0.0001
884 PSORIATIC ARTHROPATHY 4 0.0001
885 OEDEMA PERIPHERAL 12 0.0001
886 PAIN IN EXTREMITY 29 0.0001
887 FEMUR FRACTURE 3 0.0001
888 MOUTH ULCERATION 2 0.0001
889 MYALGIA 16 0.0001
890 DRUG DEPENDENCE 15 0.0001
891 DIARRHOEA 60 0.0001
892 HYPOACUSIS 4 0.0001
893 OEDEMA 5 0.0001
894 PRODUCT STORAGE ERROR 8 0.0001
895 IMPAIRED HEALING 3 0.0001
896 EYE DISORDER 3 0.0001
897 INFUSION RELATED REACTION 6 0.0001
898 URINARY RETENTION 3 0.0001
899 RASH MACULO-PAPULAR 2 0.0001
900 EYE PRURITUS 3 0.0001
901 RASH PAPULAR 2 0.0001
902 ARTHRITIS 7 0.0001
903 PANCREATITIS ACUTE 2 0.0001
904 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
905 TINNITUS 4 0.0001
906 PERICARDIAL EFFUSION 2 0.0001
907 DELIRIUM 3 0.0001
908 BURNING SENSATION 6 0.0001
909 SWELLING 8 0.0001
910 LYMPHADENOPATHY 3 0.0001
911 HYPOTENSION 17 0.0001
912 HOSPITALISATION 13 0.0001
913 PLATELET COUNT DECREASED 9 0.0001
914 BLOOD GLUCOSE DECREASED 4 0.0001
915 HYPERGLYCAEMIA 3 0.0001
916 MUSCULOSKELETAL STIFFNESS 7 0.0001
917 ABDOMINAL PAIN LOWER 2 0.0001
918 CHRONIC KIDNEY DISEASE 6 0.0001
919 HAEMATEMESIS 2 0.0001
920 INJECTION SITE SWELLING 6 0.0001
921 ANAPHYLACTIC SHOCK 2 0.0001
922 INFLAMMATION 4 0.0001
923 JOINT STIFFNESS 2 0.0001
924 PANCREATITIS 4 0.0001
925 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
926 JAUNDICE 2 0.0001
927 ARTHROPATHY 4 0.0001
928 FLATULENCE 4 0.0001
929 RHEUMATOID ARTHRITIS 8 0.0001
930 RECTAL HAEMORRHAGE 3 0.0001
931 ANGINA PECTORIS 2 0.0001
932 PSORIASIS 9 0.0001
933 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
934 ACUTE MYOCARDIAL INFARCTION 2 0.0001
935 LIVER DISORDER 3 0.0001
936 HAEMORRHAGE 7 0.0001
937 PREMATURE BABY 2 0.0001
938 HOT FLUSH 5 0.0001
939 LACRIMATION INCREASED 2 0.0001
940 CORONARY ARTERY DISEASE 2 0.0001
941 INJECTION SITE RASH 2 0.0001
942 RENAL DISORDER 3 0.0001
943 CARDIAC DISORDER 6 0.0001
944 BONE DENSITY DECREASED 2 0.0001
945 BLOOD GLUCOSE INCREASED 12 0.0001
946 ARRHYTHMIA 3 0.0001
947 COMA 3 0.0001
948 ALOPECIA 12 0.0001
949 OSTEONECROSIS 2 0.0001
950 CARDIAC ARREST 5 0.0001
951 DRUG ABUSE 5 0.0001
952 LEUKOPENIA 3 0.0001
953 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
954 PERIPHERAL SWELLING 9 0.0001
955 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
956 CEREBRAL HAEMORRHAGE 2 0.0001
957 CEREBROVASCULAR ACCIDENT 9 0.0001
958 PULMONARY EMBOLISM 5 0.0001
959 NEUROPATHY PERIPHERAL 5 0.0001
960 EYE IRRITATION 3 0.0001
961 BONE PAIN 3 0.0001
962 CATARACT 3 0.0001
963 THROMBOSIS 4 0.0000
964 COMPLETED SUICIDE 4 0.0000
965 ANAEMIA 9 0.0000
966 DEVICE EXPULSION 3 0.0000
967 MYOCARDIAL INFARCTION 8 0.0000
968 DEVICE DIFFICULT TO USE 3 0.0000
969 RENAL FAILURE 6 0.0000
970 COLITIS ULCERATIVE 2 0.0000
971 DISEASE PROGRESSION 5 0.0000
972 JOINT SWELLING 5 0.0000
973 HYPOGLYCAEMIA 2 0.0000
974 ATRIAL FIBRILLATION 4 0.0000
975 INJECTION SITE ERYTHEMA 5 0.0000
976 FLUID RETENTION 2 0.0000
977 HAEMOGLOBIN DECREASED 4 0.0000
978 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
979 MUSCULOSKELETAL PAIN 2 0.0000
980 DEPENDENCE 2 0.0000
981 HYPONATRAEMIA 2 0.0000
982 PLEURAL EFFUSION 2 0.0000
983 BREAST CANCER 3 0.0000
984 BLOOD CREATININE INCREASED 2 0.0000
985 THROMBOCYTOPENIA 3 0.0000
986 CARDIAC FAILURE 2 0.0000
987 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
988 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
989 ACUTE KIDNEY INJURY 3 0.0000
990 DEATH 16 0.0000
991 NEUTROPENIA 2 0.0000